Clínica Dermacross S.A.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria1 trial
• Hidradenitis suppurativa1 trial
• Psoriasis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 22 trials
• Phase 2/31 trial
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Celldex Therapeutics1 trial
• LEO Pharma1 trial

Running trials

• Enrolling by invitation

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT07256392· Phase 3· Celldex Therapeutics· Source

• Active, not recruiting

  Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

  NCT03886246· Phase 2· LEO Pharma· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic spontaneous urticaria1 recruiting

Closed trials

• Completed

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· Phase 2/3· Boehringer Ingelheim· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Boehringer Ingelheim· Source